STOCKHOLM, Sweden, April 11, 2003 (PRIMEZONE) -- Gambro AB (Stockholmsborsen:GAMBa) (Other OTC:GAMOF) (Other OTC:GAMBF), a leading international medical technology and healthcare company, reports the following decisions taken at the Annual General Meeting.
Board of Directors
Claes Dahlback, Sandra Austin Crayton, Wilbur H Gantz, Peter H Grassmann, Juha P Kokko, Soren Mellstig and Hakan Mogren were reelected members of the Board. Lena Torell was elected new member of the Board. At the statutory Board meeting following the Annual General Meeting, Claes Dahlback was elected Chairman and Hakan Mogren was elected Vice Chairman.
In accordance with the company's policy, Gosta Gahrton was not available for reelection, as he has reached retirement age. Bjorn Svedberg had declined to be reelected.
Dividend
The Meeting approved a dividend for 2002 of SEK 1.10 per share, with a record date of April 15, 2003. With this record date, dividends are expected to be paid from VPC (The Swedish Central Securities Depository and Clearing Organisation) on April 22, 2003.
Purchase and sale of the Company's own shares The proposal to authorize the Board to decide on the purchase and sale of the Company's own shares was approved. In short this includes authority for the Board to decide on acquisitions of own shares over the stock exchange or by public offer as well as on sales in relation to business acquisitions.
For further information please contact: Bengt Modeer, Senior Vice President, Corporate Communications tel. +46- 8-613 65 33, +46-70-513 65 33 Pia Irell, Investor Relations Director, Corporate Finance tel. +46-8- 613 65 91, +46-70-513 65 91 Kevin Smith, President Gambro Inc., Investor Relations U.S. tel. +1-303 231 4750
This information was brought to you by Waymaker http://www.waymaker.net
The following files are available for download:
http://www.waymaker.net/bitonline/2003/04/11/20030411BIT00260/wkr0001.doc
http://www.waymaker.net/bitonline/2003/04/11/20030411BIT00260/wkr0002.pdf